ASCENDIS PHARMA A/S shareholders Q3 2023

ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 164 filers reported holding ASCENDIS PHARMA A/S in Q3 2023. The put-call ratio across all filers is 1.12 and the average weighting 0.6%.

ASCENDIS PHARMA A/S shareholders Q3 2023
NameSharesValueWeighting ↓
Eventide Asset Management 575,438$53,884,0140.97%
Artisan Partners Limited Partnership 5,995,408$561,410,0050.95%
BERYLSON CAPITAL PARTNERS, LLC 2,600$243,4640.62%
Values First Advisors, Inc. 10,235$958,4120.62%
Boxer Capital, LLC 95,000$8,895,8000.47%
HARBOR CAPITAL ADVISORS, INC. 14,135$1,323,6010.28%
T. Rowe Price Investment Management, Inc. 3,984,503$373,1090.26%
HighVista Strategies LLC 5,898$552,2890.26%
JANUS HENDERSON GROUP PLC 3,854,533$360,951,7090.24%
Virtus ETF Advisers LLC 3,368$315,3800.19%
Parkwood LLC 18,097$1,6950.18%
FRED ALGER MANAGEMENT, LLC 270,005$25,283,2680.14%
JGP Global Gestao de Recursos Ltda. 2,305$215,8400.14%
TANG CAPITAL MANAGEMENT LLC 10,000$936,4000.13%
DUALITY ADVISERS, LP 10,683$1,000,3560.12%
ADAGE CAPITAL PARTNERS GP, L.L.C. 526,371$49,289,3800.11%
CenterBook Partners LP 9,524$891,8270.11%
PUTNAM INVESTMENTS LLC 772,362$72,323,9780.11%
Verition Fund Management LLC 87,112$8,157,1680.10%
Candriam S.C.A. 139,375$13,051,0750.09%
External links

This page lists ASCENDIS PHARMA A/S's shareholders in Q3 2023. To view ASCENDIS PHARMA A/S's shareholder history, click here.